- ETH’s underperformance relative to BTC hit a yearly low
- Coinbase analysts linked weak performance to investors’ interests and other factors
After peaking in March, the world’s largest altcoin, Ethereum [ETH], has continued to trail Bitcoin [BTC].
ETH hit $4k in March and attempted to retest the level after partial approval of U.S spot ETH ETFs later in the year. And yet, ETH has continued to underperform BTC.
Even July’s final ETH ETF approval didn’t help the altcoin’s underperformance. In fact, it recently hit a yearly record low of 0.040 on the ETHBTC ratio, which tracks ETH’s value relative to BTC.
Source: ETHBTC ratio, TradingView
Reasons for ETH’s dismal performance
In their latest weekly commentary, Coinbase analysts linked ETH’s weak performance to “net buyer interest divergence” based on ETF flows and other factors. Part of the report read,
“This divergence in net buyer interest is embodied in US spot ETF flows in our view. ETH ETFs have had nine consecutive days of outflows between August 15 and 27 totaling $115M, while BTC ETFs had inflows eight of those nine days netting to $427M.”
Coinbase analysts David Duong and David Han added that ETH ETFs recorded cumulative net outflows of $477 million since inception. On the contrary, BTC ETFs have netted $17.8 billion in inflows since their debut.
The same divergent trend played out when adjusted to the first month of trading. In short, BTC ETFs saw massive demand, unlike weak interest in ETH ETFs.
Source: Coinbase
However, the analysts noted that varying debut periods might have affected the flow difference too.
BTC ETFs were launched in January when liquidity was prevalent. On the other hand, ETH ETFs were launched in July amid the summer liquidity crunch, when most players were on vacation.
Analysts Han and Duong also believe that the lack of a staking feature on U.S spot ETH ETFs and competition from other smart contract chains like Solana [SOL] could have derailed ETH.
Additionally, the lack of a cohesive vision for the ETH ecosystem narrative and direction might have limited investor interest in the altcoin. Finally, the report cited recent fierce criticism of Ethereum founder Vitalik Buterin, who has been skeptical of “pure DeFi” as a crypto growth driver.
According to the analysts, divergent views and an incoherent vision could make it difficult for investors to understand ETH and its value proposition.
“This divide between thought leaders in the Ethereum community may make it challenging to understand ETH’s narrative and direction, particularly for those not familiar with the sector.”
At the time of writing, BTC was trading at $58.9k, about 20% from its March high of $73k. On the contrary, ETH was valued at $2.5k, down 38% from its March high of $4k.
- ETH’s underperformance relative to BTC hit a yearly low
- Coinbase analysts linked weak performance to investors’ interests and other factors
After peaking in March, the world’s largest altcoin, Ethereum [ETH], has continued to trail Bitcoin [BTC].
ETH hit $4k in March and attempted to retest the level after partial approval of U.S spot ETH ETFs later in the year. And yet, ETH has continued to underperform BTC.
Even July’s final ETH ETF approval didn’t help the altcoin’s underperformance. In fact, it recently hit a yearly record low of 0.040 on the ETHBTC ratio, which tracks ETH’s value relative to BTC.
Source: ETHBTC ratio, TradingView
Reasons for ETH’s dismal performance
In their latest weekly commentary, Coinbase analysts linked ETH’s weak performance to “net buyer interest divergence” based on ETF flows and other factors. Part of the report read,
“This divergence in net buyer interest is embodied in US spot ETF flows in our view. ETH ETFs have had nine consecutive days of outflows between August 15 and 27 totaling $115M, while BTC ETFs had inflows eight of those nine days netting to $427M.”
Coinbase analysts David Duong and David Han added that ETH ETFs recorded cumulative net outflows of $477 million since inception. On the contrary, BTC ETFs have netted $17.8 billion in inflows since their debut.
The same divergent trend played out when adjusted to the first month of trading. In short, BTC ETFs saw massive demand, unlike weak interest in ETH ETFs.
Source: Coinbase
However, the analysts noted that varying debut periods might have affected the flow difference too.
BTC ETFs were launched in January when liquidity was prevalent. On the other hand, ETH ETFs were launched in July amid the summer liquidity crunch, when most players were on vacation.
Analysts Han and Duong also believe that the lack of a staking feature on U.S spot ETH ETFs and competition from other smart contract chains like Solana [SOL] could have derailed ETH.
Additionally, the lack of a cohesive vision for the ETH ecosystem narrative and direction might have limited investor interest in the altcoin. Finally, the report cited recent fierce criticism of Ethereum founder Vitalik Buterin, who has been skeptical of “pure DeFi” as a crypto growth driver.
According to the analysts, divergent views and an incoherent vision could make it difficult for investors to understand ETH and its value proposition.
“This divide between thought leaders in the Ethereum community may make it challenging to understand ETH’s narrative and direction, particularly for those not familiar with the sector.”
At the time of writing, BTC was trading at $58.9k, about 20% from its March high of $73k. On the contrary, ETH was valued at $2.5k, down 38% from its March high of $4k.
where can i get clomid tablets can i buy generic clomid without dr prescription how to get clomid without dr prescription can i order generic clomid for sale get generic clomid without insurance where buy generic clomid tablets buying cheap clomid without prescription
This website exceedingly has all of the information and facts I needed adjacent to this subject and didn’t comprehend who to ask.
More posts like this would make the blogosphere more useful.
azithromycin 250mg without prescription – tindamax order metronidazole online buy
buy semaglutide 14mg generic – rybelsus ca buy cheap cyproheptadine
motilium brand – purchase sumycin buy cyclobenzaprine online cheap
buy clavulanate pill – atbioinfo.com buy acillin
nexium for sale online – nexiumtous esomeprazole 40mg oral
buy coumadin 5mg pills – coumamide order cozaar pills
prednisone 10mg pills – corticosteroid order prednisone 20mg online
cheap erectile dysfunction pills online – over the counter erectile dysfunction pills the blue pill ed
amoxil ca – https://combamoxi.com/ buy amoxicillin online
order forcan – diflucan canada order fluconazole 100mg pill
buy cenforce – on this site purchase cenforce generic
cheaper alternative to cialis – on this site tadalafil generic in usa
cheap cialis free shipping – https://strongtadafl.com/# cialis from india online pharmacy
buy cheap ranitidine – https://aranitidine.com/# buy ranitidine sale
can you really buy viagra online – https://strongvpls.com/ buy viagra express delivery
The depth in this serving is exceptional. cheap lasix
More posts like this would create the online time more useful. https://ursxdol.com/levitra-vardenafil-online/
Facts blog you procure here.. It’s severely to espy strong quality script like yours these days. I honestly appreciate individuals like you! Withstand guardianship!! https://prohnrg.com/product/priligy-dapoxetine-pills/
The thoroughness in this break down is noteworthy. https://aranitidine.com/fr/en_france_xenical/
This website positively has all of the information and facts I needed to this subject and didn’t identify who to ask. https://ondactone.com/product/domperidone/
Thanks on sharing. It’s top quality.
clopidogrel 75mg pills